David Schiff
大卫·希夫
MD
Professor of Neurology, Neurosurgery, and Medicine; Co-Director, Neuro-Oncology Center神经肿瘤中心联合主任、教授
👥Biography 个人简介
David Schiff is a leading authority on neurological complications of cancer, particularly leptomeningeal disease and brain metastases. He has written the definitive clinical references in neuro-oncology and led multi-institutional trials on CNS-directed therapies for metastatic cancer.
🧪Research Fields 研究领域
🎓Key Contributions 主要贡献
Leptomeningeal Metastases
Defined clinical approach, diagnostic standards, and treatment strategies for leptomeningeal disease from solid tumors and hematologic malignancies.
Neurological Complications of Cancer
Authored landmark textbooks on neurological complications of systemic cancer, serving as definitive clinical references for oncology.
Brain Metastases Management
Advanced evidence-based management of brain metastases through clinical trials and meta-analyses of SRS, WBRT, and systemic therapy combinations.
Representative Works 代表性著作
Clinical presentation, course, and prognostic factors in leptomeningeal carcinomatosis
Neurology (2003)
Comprehensive analysis of leptomeningeal disease natural history and predictors of survival, guiding treatment decisions.
Neurological Complications of Cancer (Oxford Textbook)
Oxford University Press (2018)
Definitive reference text covering all neurological complications of malignancy and cancer therapy, widely used in training.
🏆Awards & Recognition 奖项与荣誉
📄Data Sources 数据来源
Last updated: 2026-01-15 | All information from publicly available academic sources
Related Experts 相关专家
Timothy Cloughesy
UCLA Health / David Geffen School of Medicine
Patrick Y. Wen
Dana-Farber Cancer Institute / Harvard Medical School
Michael Weller
University Hospital Zurich / University of Zurich
Susan M. Chang
University of California San Francisco (UCSF)
关注 大卫·希夫 的研究动态
Follow David Schiff's research updates
留下邮箱，当我们发布与 David Schiff（University of Virginia School of Medicine）相关的新研究或访谈时，我们会通知你。
Explore More Experts
Discover the researchers shaping the future of cancer treatment